Main content

    Renal and Urinary Tract Cancer Clinical Trials

    CPMC Cancer ServicesOpens new window

    Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at ClinicalTrials.gov


    Active Trials

    Title: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
    Description: Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Investigators: NCI - National Cancer Institute
    Eligibility: Subjects 18 y/o and older with confirmed renal cell carcinoma
    Status: Please contact site for study status
    Contact: Peter Gasper, 415-600-3472, Email: GasperP@cpmcri.org about Study SWOG S0931 (Everest)

    Title: A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma
    Description: Study of Dalantercept in Patients With Advanced Renal Cell Carcinoma
    Investigators: Ari Baron, MD
    Eligibility: Subjects, 18 y/o and older, who have histologically confirmed, advanced, predominantly clear cell renal cell carcinoma (RCC).
    Status: Open to enrollment
    Contact: Joni Beemsterboer, 415-600-3967, Email: BeemstJ@cpmcri.org about Study Acceleron A041-04

    Title: A Phase II Single Arm Clinical Trial of Nivolumab (BMS-936558) in Subjects With Metastatic or Unresectable Urothelial Cancer Who Have Progressed or Recurred Following Treatment With a Platinum Agent
    Description: The purpose the study is to measure the effect of nivolumab (BMS-936558) in reducing tumor size in subjects with metastatic or unresectable bladder cancer
    Investigators: Ari Baron, MD
    Eligibility: Subjects, 18 y/o and older, who have evidence of metastatic or surgically unresectable transitional cell carcinoma of the urothelium involving the bladder, urethra, ureter or renal pelvis
    Status: Open to enrollment
    Contact: Madeline Decker, 415-600-3613, Email: DeckerM@cpmcri.org about Study BMS CA209-275

    • updated March 2015

    Back to top